KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Asset Utilization Ratio: 2010-2025

Historic Asset Utilization Ratio for Ionis Pharmaceuticals (IONS) over the last 15 years, with Sep 2025 value amounting to 0.26.

  • Ionis Pharmaceuticals' Asset Utilization Ratio fell 5.30% to 0.26 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26, marking a year-over-year decrease of 5.30%. This contributed to the annual value of 0.24 for FY2024, which is 17.49% down from last year.
  • Ionis Pharmaceuticals' Asset Utilization Ratio amounted to 0.26 in Q3 2025, which was down 0.79% from 0.27 recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Asset Utilization Ratio registered a high of 0.36 during Q3 2022, and its lowest value of 0.14 during Q1 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.25, with a median of 0.26 in 2025.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first surged by 163.57% in 2021, then crashed by 41.97% in 2023.
  • Ionis Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.32 in 2021, then dropped by 26.49% to 0.24 in 2022, then rose by 12.18% to 0.27 in 2023, then decreased by 12.84% to 0.23 in 2024, then dropped by 5.30% to 0.26 in 2025.
  • Its Asset Utilization Ratio was 0.26 in Q3 2025, compared to 0.27 in Q2 2025 and 0.25 in Q1 2025.